韓京

2004.09-2008.06 中國藥科大學 藥學院 製藥工程專業 學士

2008.09-2013.06 中國藥科大學 藥學院 藥物化學專業 博士

2018.07至今 江蘇師範大學副教授

2014.02至今 江蘇師範大學任教

近年來主要從事小分子及多肽類新藥分子的設計、合成及活性研究，糖尿病及肥胖領域的新藥篩選，此外在藥用新材料方向也開展了部分工作。

1. 具有降糖和減肥雙重作用的新型多肽的設計、合成及生物活性研究，國家自然科學基金

2. 新型降糖多肽及其納米緩釋製劑的設計、合成生物活性研究，江蘇省自然科學基金

1.Jing Han*, Yingying Fei, Feng Zhou, Xinyu Chen, Ying Zhang, Lin Liu, Junjie Fu. Xenopus GLP-1 derived and PEGylated GLP-1 receptor agonists: long-acting hypoglycemic and insulinotropic activities with potential therapeutic utilities.British Journal of Pharmacology, 2018, 175, 544-557.

2.Jing Han*, Yue Huang, Xinyu Chen, Feng Zhou, Yingying Fei, Junjie Fu. Rational design of dimeric lipidatedXenopusglucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents.European Journal of Medicinal Chemistry, 2018, 157, 177-187.

3.Jing Han*, Xinyu Chen, Liming Zhao, Junjie Fu, Lidan Sun, Ying Zhang, Feng Zhou, Yingying Fei. Lithocholic acid-based peptide delivery system for an enhanced pharmacological and pharmacokinetic profile ofXenopusGLP-1 analogs.Molecular Pharmaceutics, 2018, 15, 2840-2856.

4.Jing Han*, Yue Huang, Xinyu Chen, Feng Zhou, Yingying Fei, Junjie Fu. Lipidation and conformational constraining for prolonging the effects of peptides:Xenopusglucagon-like peptide 1 analogues with potent and long-acting hypoglycemic activity.European Journal of Pharmaceutical Sciences, 2018, 123, 111-123.

5.Jing Han*, Yiyun Wang, Qinghua Meng, Guangchao Li, Fangmin Huang, Su Wu, Yingying Fei, Feng Zhou, Junjie Fu. Design, synthesis and biological evaluation of PEGylatedXenopusglucagon-like peptide-1 derivatives as long-acting hypoglycemic agents.European Journal of Medicinal Chemistry, 2017, 132, 81-89.